Back
Mirum Pharmaceuticals Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer3.jpg)
Elon's New AI Device is About to Shock the World
Click here to see the details because a lot of people could get rich from this new invention.
Buy
75
MIRM
Mirum Pharmaceuticals
Last Price:
32.97
Seasonality Move:
6.63%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer6.jpg)
Jeff Bezos's Plan Exposed
And for investors who get in now profits could be massive - click here for full story.Mirum Pharmaceuticals Price Quote
$32.97
-0.18 (-0.54%)
(Updated: June 26, 2024 at 1:55 PM ET)
Mirum Pharmaceuticals Key Stats
Buy
75
Mirum Pharmaceuticals (MIRM)
is a Buy
Day range:
$33.05 - $34.98
52-week range:
$23.14 - $35.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.39
P/B ratio:
6.66%
Volume:
723.5K
Avg. volume:
802.6K
1-year change:
21.21%
Market cap:
$1.6B
Revenue:
$186.4M
EPS:
$-3.76
How Much Does Mirum Pharmaceuticals Make?
-
How Much Are Mirum Pharmaceuticals's Sales Annually?
MIRM Revenues are $186.4M -
How Much Profit Does Mirum Pharmaceuticals's Make A Year?
MIRM net income is -$163.4M
Is Mirum Pharmaceuticals Growing As A Company?
-
What Is Mirum Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.19% -
What Is Mirum Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Mirum Pharmaceuticals Stock Price Performance
-
Did Mirum Pharmaceuticals Stock Go Up Last Month?
Mirum Pharmaceuticals share price went up by 35.03% last month -
Did MIRM's Share Price Rise Over The Last Year?
MIRM share price rose by 21.21% over the past 1 year
What Is Mirum Pharmaceuticals 52-Week High & Low?
-
What Is Mirum Pharmaceuticals’s 52-Week High Share Price?
Mirum Pharmaceuticals has traded as high as $35.56 over the past 52 weeks -
What Is Mirum Pharmaceuticals’s 52-Week Low Share Price?
Mirum Pharmaceuticals has traded as low as $23.14 over the past 52 weeks
Mirum Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Mirum Pharmaceuticals?
-
How Much Debt Does Mirum Pharmaceuticals Have?
Total long term debt quarterly is $306.8M -
How Much Cash Does Mirum Pharmaceuticals Have?
Cash and short term investments quarterly total is $302.8M -
What Is Mirum Pharmaceuticals’s Book Value Per Share?
Book value per share is 4.99
Is Mirum Pharmaceuticals Cash Flow Positive?
-
What Is MIRM Cash Flow From Operations?
Cash flow from operations (TTM) is -$37M -
What Is Mirum Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $324.8M -
What Is Mirum Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$134.2M
Mirum Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
MIRM return on invested capital is -36.09% -
What Is Mirum Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -29.08% -
What Is MIRM Return On Equity?
ROE is a measure of profitability and is -81.56%
Mirum Pharmaceuticals Earnings Date & Stock Price
-
What Is Mirum Pharmaceuticals's Stock Price Today?
A single share of MIRM can be purchased today for 33.15 -
What Is Mirum Pharmaceuticals’s Stock Symbol?
Mirum Pharmaceuticals trades on the nasdaq under the ticker symbol: MIRM -
When Is Mirum Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Mirum Pharmaceuticals is scheduled on August 2, 2024 -
When Is MIRM's next ex-dividend date?
Mirum Pharmaceuticals's next ex-dividend date is June 26, 2024 -
How To Buy Mirum Pharmaceuticals Stock?
You can buy Mirum Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Mirum Pharmaceuticals Competitors
-
Who Are Mirum Pharmaceuticals's Competitors?
Below is a list of companies who compete with Mirum Pharmaceuticals or are related in some way:
Mirum Pharmaceuticals Dividend Yield
Data Unavailable
Mirum Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -77.26% |
Revenue: | 119.07% | -1.35% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 56.36 |
Upside from Last Price: | 70.03% |